{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:44:20Z","timestamp":1791776660468,"version":"4.3.4"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.intimp.2023.110872","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T12:52:56Z","timestamp":1693572776000},"page":"110872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"PA","title":["Immune system roles in pathogenesis, prognosis, control, and treatment of Toxoplasma gondii infection"],"prefix":"10.1016","volume":"124","author":[{"given":"Mohammad Mahdi","family":"Jafari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Azimzadeh Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Saaid","family":"Dayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin Atieh","family":"Kazemi-Sefat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Mohtashamifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahimeh","family":"Mohseni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Bahadory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Karimipour-Saryazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0891-8214","authenticated-orcid":false,"given":"Fatemeh","family":"Ghaffarifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.intimp.2023.110872_b0005","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.ijpara.2008.03.007","article-title":"Toxoplasma gondii infection in humans and animals in the United States","volume":"38","author":"Dubey","year":"2008","journal-title":"Int. J. Parasitol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-4-165","article-title":"Toxoplasma gondii infection in humans in China","volume":"4","author":"Zhou","year":"2011","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.intimp.2023.110872_b0015","doi-asserted-by":"crossref","first-page":"e00102","DOI":"10.1016\/j.fawpar.2020.e00102","article-title":"Mathematical modelling of Toxoplasma gondii transmission: A systematic review","volume":"22","author":"Deng","year":"2021","journal-title":"Food Waterborne Parasitol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110872_b0020","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/605433","article-title":"Risk factors for Toxoplasma gondii infection in the United States","volume":"49","author":"Jones","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2023.110872_b0025","doi-asserted-by":"crossref","first-page":"e97775","DOI":"10.1371\/journal.pone.0097775","article-title":"A meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.110872_b0030","unstructured":"S. Mehbod et al., Seroepidemiology assay of toxoplasmosis in infants who was confined to bed in infants ward of Taleghani hospital during 1379-1380, 2005."},{"issue":"4","key":"10.1016\/j.intimp.2023.110872_b0035","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S2352-3018(17)30005-X","article-title":"Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis","volume":"4","author":"Wang","year":"2017","journal-title":"The Lancet HIV"},{"issue":"4","key":"10.1016\/j.intimp.2023.110872_b0040","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/S2352-3018(17)30003-6","article-title":"Toxoplasma gondii and HIV: a never-ending story","volume":"4","author":"Nissapatorn","year":"2017","journal-title":"The Lancet HIV"},{"key":"10.1016\/j.intimp.2023.110872_b0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fcimb.2019.00185","article-title":"Disease tolerance in Toxoplasma infection","volume":"9","author":"Melchor","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110872_b0050","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.pt.2013.10.002","article-title":"Regulation of immunopathogenesis during Plasmodium and Toxoplasma infections: more parallels than distinctions?","volume":"29","author":"Butler","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.intimp.2023.110872_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.580425","article-title":"Influence of the host and parasite strain on the immune response during Toxoplasma infection","volume":"10","author":"Mukhopadhyay","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2023.110872_b0060","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3389\/fimmu.2020.00390","article-title":"A Proinflammatory Immune Response Might Determine Toxoplasma gondii Vertical Transmission and Severity of Clinical Features in Congenitally Infected Newborns","volume":"11","author":"G\u00f3mez-Ch\u00e1vez","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110872_b0065","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2217\/fmb.10.97","article-title":"Advances in imaging the innate and adaptive immune response to Toxoplasma gondii","volume":"5","author":"John","year":"2010","journal-title":"Future Microbiol."},{"key":"10.1016\/j.intimp.2023.110872_b0070","series-title":"Seminars in Immunopathology","article-title":"Immune response and immunopathology during toxoplasmosis","author":"Dupont","year":"2012"},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0075","doi-asserted-by":"crossref","first-page":"e00115","DOI":"10.1128\/CMR.00115-19","article-title":"Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis","volume":"34","author":"Elsheikha","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2023.110872_b0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/sj.icb.7100038","article-title":"Cytokine regulation of immunopathology in toxoplasmosis","volume":"85","author":"Gaddi","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.intimp.2023.110872_b0085","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/910621","article-title":"Biomarker analysis revealed distinct profiles of innate and adaptive immunity in infants with ocular lesions of congenital toxoplasmosis","volume":"2014","author":"Machado","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-019-0006-5","article-title":"Toxoplasmosis and abortion: pro-and anti-inflammatory cytokines gene expression of the host immune cells","volume":"20","author":"El-Sherbini","year":"2019","journal-title":"Egypt. J. Medical Human Genet."},{"issue":"7","key":"10.1016\/j.intimp.2023.110872_b0095","doi-asserted-by":"crossref","first-page":"e12712","DOI":"10.1111\/pim.12712","article-title":"The role of macrophages in protective and pathological responses to Toxoplasma gondii","volume":"42","author":"Park","year":"2020","journal-title":"Parasite Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110872_b0100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/MMBR.00027-15","article-title":"Long-term relationships: the complicated interplay between the host and the developmental stages of Toxoplasma gondii during acute and chronic infections","volume":"79","author":"Pittman","year":"2015","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.intimp.2023.110872_b0105","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3389\/fimmu.2018.01648","article-title":"Galectin-3 and Galectin-9 may differently regulate the expressions of microglial M1\/M2 markers and T helper 1\/Th2 cytokines in the brains of genetically susceptible C57BL\/6 and resistant BALB\/c mice following peroral infection with Toxoplasma gondii","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110872_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105657","article-title":"Recent advances in treatment Crimean-Congo hemorrhagic fever virus: A concise overview","author":"Gholizadeh","year":"2022","journal-title":"Microb. Pathog."},{"issue":"3","key":"10.1016\/j.intimp.2023.110872_b0115","first-page":"121","article-title":"Possible Cellular Expression of IFN\u03b3 in woman with abortion infected Toxoplasma gondii","volume":"16","author":"Al-Fertosi","year":"2006","journal-title":"Med. J. Islamic World Acad. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2023.110872_b0120","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/infdis\/jiw041","article-title":"Cytokine signatures associated with early onset, active lesions and late cicatricial events of retinochoroidal commitment in infants with congenital toxoplasmosis","volume":"213","author":"Carneiro","year":"2016","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/MJBL.MJBL_13_18","article-title":"Immune profile in aborted Iraqi women with toxoplasmosis","volume":"15","author":"Aldabagh","year":"2018","journal-title":"Med. J. Babylon"},{"key":"10.1016\/j.intimp.2023.110872_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-019-0006-5","article-title":"Toxoplasmosis and abortion: pro-and anti-inflammatory cytokines gene expression of the host immune cells","volume":"20","author":"El-Sherbini","year":"2019","journal-title":"Egypt. J. Medical Human Genet."},{"key":"10.1016\/j.intimp.2023.110872_b0135","first-page":"281","article-title":"Gene expression of two innate cytokines in a miscarriage toxoplasmosis woman","volume":"67","author":"Mousa","year":"2021","journal-title":"Ann Parasitol"},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14302\/issn.2690-6759.jpar-19-2971","article-title":"Cytokines Level (il8 and Il17) in Pregnant Women With Toxoplasmosis in Khartoum State","volume":"1","author":"Satti","year":"2019","journal-title":"J. Parasite Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-73265-z","article-title":"Putative biomarkers for early diagnosis and prognosis of congenital ocular toxoplasmosis","volume":"10","author":"de Ara\u00fajo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.110872_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2015.11.004","article-title":"IgA and IgG1 reactivities assessed by flow cytometry mirror clinical aspects of infants with ocular congenital toxoplasmosis","volume":"428","author":"de Jesus","year":"2016","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.intimp.2023.110872_b0155","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bjophthalmol-2019-315522","article-title":"Ocular toxoplasmosis: phenotype differences between toxoplasma IgM positive and IgM negative patients in a large cohort","volume":"105","author":"Ajamil-Rodanes","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.intimp.2023.110872_b0160","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1590\/S0036-46651999000600001","article-title":"Detection of Toxoplasma gondii soluble antigen, SAG-1 (p30), antibody and immune complex in the cerebrospinal fluid of HIV positive or negative individuals","volume":"41","author":"Chaves-Borges","year":"1999","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"issue":"22","key":"10.1016\/j.intimp.2023.110872_b0165","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1073\/pnas.1015298108","article-title":"Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1\u2013PDL-1 blockade","volume":"108","author":"Bhadra","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.intimp.2023.110872_b0170","doi-asserted-by":"crossref","first-page":"e00036","DOI":"10.1016\/j.fawpar.2019.e00036","article-title":"Treatment of toxoplasmosis: Current options and future perspectives","volume":"15","author":"Konstantinovic","year":"2019","journal-title":"Food Waterborne Parasitol."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2023.110872_b0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpara.2020.11.001","article-title":"Control of human toxoplasmosis","volume":"51","author":"Smith","year":"2021","journal-title":"Int. J. Parasitol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110872_b0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3347\/kjp.2001.39.3.233","article-title":"Effects of specific monoclonal antibodies to dense granular proteins on the invasion of Toxoplasma gondii in vitro and in vivo","volume":"39","author":"Cha","year":"2001","journal-title":"Korean J. Parasitol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110872_b0185","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1017\/S0031182020000177","article-title":"Production and characterization of monoclonal antibodies against Toxoplasma gondii ROP18 with strain-specific reactivity","volume":"147","author":"Zhang","year":"2020","journal-title":"Parasitology"},{"issue":"2","key":"10.1016\/j.intimp.2023.110872_b0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"issue":"15","key":"10.1016\/j.intimp.2023.110872_b0195","doi-asserted-by":"crossref","first-page":"e2004433","DOI":"10.1002\/advs.202004433","article-title":"Cytokines: From Clinical Significance to Quantification","volume":"8","author":"Liu","year":"2021","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"10.1016\/j.intimp.2023.110872_b0200","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1128\/IAI.01722-14","article-title":"Complex immune cell interplay in the gamma interferon response during Toxoplasma gondii infection","volume":"82","author":"Sturge","year":"2014","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.intimp.2023.110872_b0205","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijpara.2005.12.003","article-title":"Toll-like receptor recognition of Toxoplasma gondii","volume":"36","author":"Yarovinsky","year":"2006","journal-title":"Int. J. Parasitol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110872_b0210","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12516","article-title":"Group 1 innate lymphoid cells in Toxoplasma gondii infection","volume":"40","author":"Dunay","year":"2018","journal-title":"Parasite Immunol."},{"issue":"13","key":"10.1016\/j.intimp.2023.110872_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110564","article-title":"Type 1 innate lymphoid cells regulate the onset of Toxoplasma gondii-induced neuroinflammation","volume":"38","author":"Steffen","year":"2022","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.intimp.2023.110872_b0220","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s00436-021-07204-w","article-title":"The role of IL-12 in stimulating NK cells against Toxoplasma gondii infection: a mini-review","volume":"120","author":"Mahmoudzadeh","year":"2021","journal-title":"Parasitol. Res."},{"issue":"6","key":"10.1016\/j.intimp.2023.110872_b0225","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.immuni.2012.03.026","article-title":"NK cell-derived interferon-gamma orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection","volume":"36","author":"Goldszmid","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110872_b0230","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65614","article-title":"IL-33 promotes innate lymphoid cell-dependent IFN-gamma production required for innate immunity to Toxoplasma gondii","volume":"10","author":"Clark","year":"2021","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0235","doi-asserted-by":"crossref","first-page":"13115","DOI":"10.1038\/s41598-020-70102-1","article-title":"Treatment of mice with S4B6 IL-2 complex prevents lethal toxoplasmosis via IL-12- and IL-18-dependent interferon-gamma production by non-CD4 immune cells","volume":"10","author":"Kupz","year":"2020","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.intimp.2023.110872_b0240","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1128\/IAI.70.9.4757-4761.2002","article-title":"Susceptibility of interleukin-2-deficient mice to Toxoplasma gondii is associated with a defect in the production of gamma interferon","volume":"70","author":"Villegas","year":"2002","journal-title":"Infect. Immun."},{"issue":"5728","key":"10.1016\/j.intimp.2023.110872_b0245","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.1109893","article-title":"TLR11 activation of dendritic cells by a protozoan profilin-like protein","volume":"308","author":"Yarovinsky","year":"2005","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.intimp.2023.110872_b0250","first-page":"901","article-title":"Assessment of DNA vaccine encoding Toxoplasma gondii microneme complete gene and IL-12 as adjuvant in BALB\/c mice","volume":"22","author":"Ghaffarifar","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2023.110872_b0255","doi-asserted-by":"crossref","first-page":"e10842","DOI":"10.1371\/journal.pone.0010842","article-title":"Absence of both IL-7 and IL-15 severely impairs the development of CD8 T cell response against Toxoplasma gondii","volume":"5","author":"Bhadra","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/infdis\/jis304","article-title":"PD-1-mediated attrition of polyfunctional memory CD8+ T cells in chronic toxoplasma infection","volume":"206","author":"Bhadra","year":"2012","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.intimp.2023.110872_b0265","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4049\/jimmunol.0901843","article-title":"IL-6 promotes NK cell production of IL-17 during toxoplasmosis","volume":"184","author":"Passos","year":"2010","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110872_b0270","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1172\/JCI136226","article-title":"The molecular biology and immune control of chronic Toxoplasma gondii infection","volume":"130","author":"Zhao","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.intimp.2023.110872_b0275","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1128\/IAI.00784-12","article-title":"Donor CD8+ T cells prevent Toxoplasma gondii de-encystation but fail to rescue the exhausted endogenous CD8+ T cell population","volume":"81","author":"Bhadra","year":"2013","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.intimp.2023.110872_b0280","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.micinf.2018.05.003","article-title":"Control of pathogens and microbiota by innate lymphoid cells","volume":"20","author":"Cording","year":"2018","journal-title":"Microbes Infect."},{"issue":"Supplement_1","key":"10.1016\/j.intimp.2023.110872_b0285","doi-asserted-by":"crossref","first-page":"hcaa060","DOI":"10.1093\/qjmed\/hcaa060","article-title":"Mesenchymal stem cells reduce both inflammation and mortality in chronic cerebral murine toxoplasmosis","volume":"113","author":"Elhosseiny","year":"2020","journal-title":"QJM: Int. J. Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.110872_b0290","doi-asserted-by":"crossref","first-page":"e1005396","DOI":"10.1371\/journal.ppat.1005396","article-title":"The diverse role of NK cells in immunity to Toxoplasma gondii infection","volume":"12","author":"Gigley","year":"2016","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0295","first-page":"34","article-title":"The Outcomes of Mesenchymal Stem Cells Therapy for Experimental Toxoplasmosis","volume":"12","author":"Etewa","year":"2019","journal-title":"Parasitol. United J."},{"issue":"5","key":"10.1016\/j.intimp.2023.110872_b0300","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3347\/kjp.2013.51.5.573","article-title":"Detection of acute toxoplasmosis in pigs using loop-mediated isothermal amplification and quantitative PCR","volume":"51","author":"Wang","year":"2013","journal-title":"Korean J. Parasitol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2001-1326-3-24","article-title":"Stem cell delivery of therapies for brain disorders","volume":"3","author":"Aleynik","year":"2014","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-018-1008-9","article-title":"The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure","volume":"9","author":"He","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"10.1016\/j.intimp.2023.110872_b0315","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1258\/ebm.2012.011362","article-title":"Mesenchymal stem cells relieve fibrosis of Schistosoma japonicum-induced mouse liver injury","volume":"237","author":"Xu","year":"2012","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.intimp.2023.110872_b0320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.imlet.2015.12.002","article-title":"Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice","volume":"170","author":"Dameshghi","year":"2016","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.intimp.2023.110872_b0325","first-page":"129","article-title":"Potential Therapeutic Effect of Allogenic Mesenchymal Stem Cells on Chronic Cerebral Murine Toxoplasmosis","volume":"10","author":"Ashkar","year":"2020","journal-title":"Afro-Egyptian J. Infect. Endemic Diseases"},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0330","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/rheumatology\/kem284","article-title":"Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis","volume":"47","author":"Zheng","year":"2008","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.intimp.2023.110872_b0335","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2003-04-1193","article-title":"Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals","volume":"102","author":"Djouad","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2023.110872_b0340","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/ijms19020558","article-title":"Recent updates on treatment of ocular microbial infections by stem cell therapy: a review","volume":"19","author":"Teh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-10-106","article-title":"Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury","volume":"10","author":"Zhang","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.intimp.2023.110872_b0350","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.immuni.2012.06.009","article-title":"A cluster of interferon-\u03b3-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii","volume":"37","author":"Yamamoto","year":"2012","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2023.110872_b0355","doi-asserted-by":"crossref","first-page":"e1003320","DOI":"10.1371\/journal.ppat.1003320","article-title":"Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii","volume":"9","author":"Selleck","year":"2013","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MOH.0b013e32831ac517","article-title":"The roles of cathelicidin LL-37 in immune defences and novel clinical applications","volume":"16","author":"Nijnik","year":"2009","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.intimp.2023.110872_b0365","doi-asserted-by":"crossref","unstructured":"A. Qin et al., Guanylate-binding protein 1 (GBP1) contributes to the immunity of human mesenchymal stromal cells against Toxoplasma gondii. Proc. Nat. Acad. Sc. 114(6) (2017) 1365-1370.","DOI":"10.1073\/pnas.1619665114"},{"issue":"3","key":"10.1016\/j.intimp.2023.110872_b0370","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00430-012-0281-y","article-title":"Antimicrobial effects of murine mesenchymal stromal cells directed against Toxoplasma gondii and Neospora caninum: role of immunity-related GTPases (IRGs) and guanylate-binding proteins (GBPs)","volume":"202","author":"Spekker","year":"2013","journal-title":"Med. Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110872_b0375","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.mib.2011.07.002","article-title":"The IRG protein-based resistance mechanism in mice and its relation to virulence in Toxoplasma gondii","volume":"14","author":"Howard","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110872_b0380","doi-asserted-by":"crossref","first-page":"7729","DOI":"10.4049\/jimmunol.179.11.7729","article-title":"Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense","volume":"179","author":"Degrandi","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110872_b0385","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/intimm\/dxy004","article-title":"Host immune responses to Toxoplasma gondii","volume":"30","author":"Sasai","year":"2018","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110872_b0390","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"issue":"6237","key":"10.1016\/j.intimp.2023.110872_b0395","doi-asserted-by":"crossref","first-page":"aaa6566","DOI":"10.1126\/science.aaa6566","article-title":"Innate lymphoid cells: a new paradigm in immunology","volume":"348","author":"Eberl","year":"2015","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.intimp.2023.110872_b0400","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/immunohorizons.2200070","article-title":"Impact of MyD88, Microbiota, and Location on Type 1 and Type 3 Innate Lymphoid Cells during Toxoplasma gondii Infection","volume":"6","author":"Snyder","year":"2022","journal-title":"ImmunoHorizons"},{"issue":"2","key":"10.1016\/j.intimp.2023.110872_b0405","doi-asserted-by":"crossref","first-page":"e12516","DOI":"10.1111\/pim.12516","article-title":"Group 1 innate lymphoid cells in Toxoplasma gondii infection","volume":"40","author":"Dunay","year":"2018","journal-title":"Parasite Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110872_b0410","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ni.2002","article-title":"ROR\u03b3t+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota","volume":"12","author":"Sawa","year":"2011","journal-title":"Nature Immunol"},{"issue":"5","key":"10.1016\/j.intimp.2023.110872_b0415","doi-asserted-by":"crossref","first-page":"e0128335","DOI":"10.1371\/journal.pone.0128335","article-title":"The group 3 innate lymphoid cell defect in aryl hydrocarbon receptor deficient mice is associated with T cell hyperactivation during intestinal infection","volume":"10","author":"Wagage","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.intimp.2023.110872_b0420","doi-asserted-by":"crossref","first-page":"e1009970","DOI":"10.1371\/journal.ppat.1009970","article-title":"Induction of IL-12p40 and type 1 immunity by Toxoplasma gondii in the absence of the TLR-MyD88 signaling cascade","volume":"17","author":"Snyder","year":"2021","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.intimp.2023.110872_b0425","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41577-020-0282-9","article-title":"Plasticity of innate lymphoid cell subsets","volume":"20","author":"Bal","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"6284","key":"10.1016\/j.intimp.2023.110872_b0430","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.aad2035","article-title":"Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes","volume":"352","author":"Mackay","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.intimp.2023.110872_b0435","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2017.09.052","article-title":"ILC1 confer early host protection at initial sites of viral infection","volume":"171","author":"Weizman","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.intimp.2023.110872_b0440","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.immuni.2016.03.007","article-title":"Transforming growth factor-\u03b2 signaling guides the differentiation of innate lymphoid cells in salivary glands","volume":"44","author":"Cortez","year":"2016","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2023.110872_b0445","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","article-title":"Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages","volume":"157","author":"Klose","year":"2014","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2023.110872_b0450","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1172\/JCI66381","article-title":"Liver-resident NK cells confer adaptive immunity in skin-contact inflammation","volume":"123","author":"Peng","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.intimp.2023.110872_b0455","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41590-019-0425-y","article-title":"Subsets of ILC3\u2212 ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues","volume":"20","author":"Cella","year":"2019","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110872_b0460","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","article-title":"Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12-and IL-15-responsive IFN-\u03b3-producing cells","volume":"38","author":"Fuchs","year":"2013","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2023.110872_b0465","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni.2534","article-title":"Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues","volume":"14","author":"Bernink","year":"2013","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110872_b0470","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.1501491","article-title":"CD4+ group 1 innate lymphoid cells (ILC) form a functionally distinct ILC subset that is increased in systemic sclerosis","volume":"196","author":"Roan","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110872_b0475","series-title":"Innate lymphoid cells and parasites: ancient foes with shared history","first-page":"e12513","author":"Neill","year":"2018"},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0480","doi-asserted-by":"crossref","first-page":"e1008299","DOI":"10.1371\/journal.ppat.1008299","article-title":"T-bet-dependent ILC1-and NK cell-derived IFN-\u03b3 mediates cDC1-dependent host resistance against Toxoplasma gondii","volume":"17","author":"L\u00f3pez-Yglesias","year":"2021","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.intimp.2023.110872_b0485","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jaci.2016.09.009","article-title":"Human innate lymphoid cells","volume":"138","author":"Mj\u00f6sberg","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0490","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.immuni.2012.04.011","article-title":"Commensal bacteria calibrate the activation threshold of innate antiviral immunity","volume":"37","author":"Abt","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110872_b0495","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fimmu.2016.00426","article-title":"Type 1 innate lymphoid cell biology: lessons learnt from natural killer cells","volume":"7","author":"Jiao","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110872_b0500","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells\u2014a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0505","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0510","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-065X.2008.00666.x","article-title":"Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future","volume":"224","author":"Da\u00ebron","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2023.110872_b0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102226","article-title":"Immune responses to Toxoplasma gondii","volume":"77","author":"Khan","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2023.110872_b0520","doi-asserted-by":"crossref","unstructured":"J. Coombes, C. Hunter, Immunity to Toxoplasma gondii\u2013into the 21st century, Wiley Online Library, 2015, p. 105-107.","DOI":"10.1111\/pim.12177"},{"issue":"2","key":"10.1016\/j.intimp.2023.110872_b0525","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1128\/IAI.70.2.434-443.2002","article-title":"CD8+-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4+ T cells","volume":"70","author":"Casciotti","year":"2002","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.intimp.2023.110872_b0530","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1128\/IAI.73.8.4913-4921.2005","article-title":"NK cells help to induce CD8+-T-cell immunity against Toxoplasma gondii in the absence of CD4+ T cells","volume":"73","author":"Combe","year":"2005","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.intimp.2023.110872_b0535","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/imt.11.68","article-title":"The CD8 T-cell road to immunotherapy of toxoplasmosis","volume":"3","author":"Bhadra","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.intimp.2023.110872_b0540","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fcimb.2019.00136","article-title":"Toxoplasma gondii: CD8 T cells cry for CD4 help","volume":"9","author":"Khan","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2023.110872_b0545","series-title":"Seminars in Immunopathology","article-title":"Characteristics and critical function of CD8+ T cells in the Toxoplasma-infected brain","author":"Landrith","year":"2015"},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0550","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/infdis\/jis304","article-title":"PD-1\u2013mediated attrition of polyfunctional memory CD8+ T cells in chronic Toxoplasma infection","volume":"206","author":"Bhadra","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.intimp.2023.110872_b0555","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/243796","article-title":"CD8 T cells and Toxoplasma gondii: a new paradigm","author":"Gigley","year":"2011","journal-title":"J. Parasitol. Res."},{"key":"10.1016\/j.intimp.2023.110872_b0560","series-title":"Seminars in Immunopathology","article-title":"CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection","author":"Hwang","year":"2015"},{"issue":"5","key":"10.1016\/j.intimp.2023.110872_b0565","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s11095-017-2123-5","article-title":"Achieving the promise of therapeutic extracellular vesicles: the devil is in details of therapeutic loading","volume":"34","author":"Sutaria","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.intimp.2023.110872_b0570","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/657086","article-title":"Exosomes: novel biomarkers for clinical diagnosis","author":"Lin","year":"2015","journal-title":"Sci. World J."},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-0991-5","article-title":"Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance","volume":"18","author":"Mashouri","year":"2019","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2023.110872_b0580","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1128\/IAI.72.7.4127-4137.2004","article-title":"Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection","volume":"72","author":"Aline","year":"2004","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.intimp.2023.110872_b0585","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.vaccine.2009.01.022","article-title":"Exosomes are an effective vaccine against congenital toxoplasmosis in mice","volume":"27","author":"Beauvillain","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2023.110872_b0590","series-title":"Seminars in Cell & Developmental Biology","article-title":"Exosomes and their roles in immune regulation and cancer","author":"Greening","year":"2015"},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0595","first-page":"29","article-title":"The role of exosomes in infectious diseases","volume":"12","author":"Mahmoodzadeh Hosseini","year":"2013","journal-title":"Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy)(Discontinued)"},{"key":"10.1016\/j.intimp.2023.110872_b0600","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fimmu.2014.00518","article-title":"Immunotherapeutic potential of extracellular vesicles","volume":"5","author":"Zhang","year":"2014","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110872_b0605","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3347\/kjp.2020.58.2.185","article-title":"Immunogenicity of exosomes from dendritic cells stimulated with toxoplasma gondii lysates in ocularly immunized mice","volume":"58","author":"Jung","year":"2020","journal-title":"Korean J. Parasitol."},{"key":"10.1016\/j.intimp.2023.110872_b0610","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.711565","article-title":"Exosome-based vaccines: history, current state, and clinical trials","volume":"12","author":"Santos","year":"2021","journal-title":"Front. Immunol."},{"issue":"14\u201315","key":"10.1016\/j.intimp.2023.110872_b0615","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.micinf.2007.07.002","article-title":"A vaccine based on exosomes secreted by a dendritic cell line confers protection against T. gondii infection in syngeneic and allogeneic mice","volume":"9","author":"Beauvillain","year":"2007","journal-title":"Microbes Infect."},{"key":"10.1016\/j.intimp.2023.110872_b0620","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-pharmtox-010814-124630","article-title":"Therapeutic applications of extracellular vesicles: clinical promise and open questions","volume":"55","author":"Gy\u00f6rgy","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2023.110872_b0625","series-title":"Seminars in immunopathology","article-title":"Exosomes: immune properties and potential clinical implementations","author":"Chaput","year":"2011"},{"issue":"6","key":"10.1016\/j.intimp.2023.110872_b0630","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.3390\/v7062770","article-title":"Exosomes and their role in the life cycle and pathogenesis of RNA viruses","volume":"7","author":"Chahar","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2023.110872_b0635","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/832057","article-title":"Extracellular vesicles: role in inflammatory responses and potential uses in vaccination in cancer and infectious diseases","author":"Campos","year":"2015","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2023.110872_b0640","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/B978-0-12-396481-6.00026-X","article-title":"Vaccination against toxoplasmosis: current status and future prospects","author":"Roberts","year":"2014","journal-title":"Toxoplasma gondii"},{"issue":"6","key":"10.1016\/j.intimp.2023.110872_b0645","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.ymthe.2021.04.020","article-title":"Extracellular vesicles in neuroinflammation: pathogenesis, diagnosis, and therapy","volume":"29","author":"Ruan","year":"2021","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2023.110872_b0650","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s11064-020-02998-0","article-title":"MSCs-derived exosomes attenuate acute brain injury and inhibit microglial inflammation by reversing CysLT2R-ERK1\/2 mediated microglia M1 polarization","volume":"45","author":"Zhao","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.intimp.2023.110872_b0655","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110872_b0660","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fmed.2019.00267","article-title":"The neurotropic parasite Toxoplasma gondii induces astrocyte polarization through NF\u03baB pathway","volume":"6","author":"Jin","year":"2019","journal-title":"Front. Med."},{"issue":"4","key":"10.1016\/j.intimp.2023.110872_b0665","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1159\/000494652","article-title":"Mesenchymal stem cell-derived exosomes reduce A1 astrocytes via downregulation of phosphorylated NF\u03baB P65 subunit in spinal cord injury","volume":"50","author":"Wang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2023.110872_b0670","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1590\/S0074-02762009000200027","article-title":"Treating ocular toxoplasmosis: current evidence","volume":"104","author":"Stanford","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"8","key":"10.1016\/j.intimp.2023.110872_b0675","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/bjo.82.8.858","article-title":"Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis","volume":"82","author":"Bosch-Driessen","year":"1998","journal-title":"Br. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110872_b0680","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/09273948.2015.1057599","article-title":"Fulminant ocular toxoplasmosis: the hazards of corticosteroid monotherapy","volume":"24","author":"Oray","year":"2016","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-1947-8-110","article-title":"Anaphylactic reaction to intravenous corticosteroids in the treatment of ocular toxoplasmosis: a case report","volume":"8","author":"Fie\u00df","year":"2014","journal-title":"J Med Case Reports"},{"issue":"8","key":"10.1016\/j.intimp.2023.110872_b0690","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/infdis\/jis486","article-title":"Interleukin 17A as an effective target for anti-inflammatory and antiparasitic treatment of toxoplasmic uveitis","volume":"206","author":"Sauer","year":"2012","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0695","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2217\/fmb.11.147","article-title":"IL-6 signaling SOCS critical for IL-12 host response to Toxoplasma gondii","volume":"7","author":"Mirpuri","year":"2012","journal-title":"Future Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110872_b0700","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/187221307779815039","article-title":"Infectious complications with anti-TNF\u03b1 therapy in rheumatic diseases: a review","volume":"1","author":"Toussirot","year":"2007","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"issue":"3","key":"10.1016\/j.intimp.2023.110872_b0705","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/157488706778250131","article-title":"Use of etanercept in the treatment of psoriasis and psoriatic arthritis","volume":"1","author":"Fuchs","year":"2006","journal-title":"Rev. Recent Clin. Trials"},{"key":"10.1016\/j.intimp.2023.110872_b0710","doi-asserted-by":"crossref","unstructured":"J. Braun et al., Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly, 2007.","DOI":"10.1093\/rheumatology\/kem069"},{"issue":"4","key":"10.1016\/j.intimp.2023.110872_b0715","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s12639-015-0712-y","article-title":"In vivo effect of anti-TNF agent (etanercept) in reactivation of latent toxoplasmosis","volume":"40","author":"El-Sayed","year":"2016","journal-title":"J. Parasit. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2023.110872_b0720","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.parint.2013.02.003","article-title":"Incidence of Toxoplasma retinochoroiditis in patients with ankylosing spondylitis after using TNF-alpha blockers","volume":"62","author":"Rodrigues","year":"2013","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.intimp.2023.110872_b0725","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110872_b0730","doi-asserted-by":"crossref","first-page":"e1005169","DOI":"10.1371\/journal.ppat.1005169","article-title":"Parasite glycobiology: a bittersweet symphony","volume":"11","author":"Rodrigues","year":"2015","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.intimp.2023.110872_b0735","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrd3012","article-title":"Carbohydrate vaccines: developing sweet solutions to sticky situations?","volume":"9","author":"Astronomo","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.intimp.2023.110872_b0740","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/glycob\/cwv040","article-title":"Investigation of the protective properties of glycosylphosphatidylinositol-based vaccine candidates in a Toxoplasma gondii mouse challenge model","volume":"25","author":"G\u00f6tze","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.intimp.2023.110872_b0745","doi-asserted-by":"crossref","unstructured":"J.S. Chahal et al., Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose, Proc. Nat. Acad. Sci. 113(29) (2016) E4133-E4142.","DOI":"10.1073\/pnas.1600299113"},{"key":"10.1016\/j.intimp.2023.110872_b0750","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s11095-017-2123-5","article-title":"Achieving the promise of therapeutic extracellular vesicles: the devil is in details of therapeutic loading","volume":"34","author":"Sutaria","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.intimp.2023.110872_b0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-0991-5","article-title":"Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance","volume":"18","author":"Mashouri","year":"2019","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2023.110872_b0760","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41579-021-00518-7","article-title":"Toxoplasma gondii infection and its implications within the central nervous system","volume":"19","author":"Matta","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.intimp.2023.110872_b0765","doi-asserted-by":"crossref","first-page":"e65614","DOI":"10.7554\/eLife.65614","article-title":"IL-33 promotes innate lymphoid cell-dependent IFN-\u03b3 production required for innate immunity to Toxoplasma gondii","volume":"10","author":"Clark","year":"2021","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.intimp.2023.110872_b0770","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.immuni.2012.03.026","article-title":"NK cell-derived interferon-\u03b3 orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection","volume":"36","author":"Goldszmid","year":"2012","journal-title":"Immunity"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923011979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923011979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:00:12Z","timestamp":1761588012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923011979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":154,"alternative-id":["S1567576923011979"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110872","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune system roles in pathogenesis, prognosis, control, and treatment of Toxoplasma gondii infection","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110872"}}